Back to Market Feed

DUPIXENT 200 MG/1.14 ML SYRING

Dupilumab
$1774.7500per ML

Strength

200 mg/1.14mL

NDC

00024591801

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

DUPILUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761055

On Market Since

10/19/2018

Pharmacological Classes

Antibodies
Monoclonal
Interleukin 4 Receptor alpha Antagonists
Interleukin-4 Receptor alpha Antagonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.1%

1Y

+4.6%

3Y

+16.0%

5Y

+29.9%

All

+29.9%

Generic Alternatives

Save up to 0%

1 alternative • Same active ingredient

DUPIXENT 200 MG/1.14 ML PEN
Brand
00024591902•Sanofi-Aventis U.S. LLC
$1772.9914
Save 0%

Related Drugs

Same classification

PRALUENT 75 MG/ML PEN
Brand
61755002002•Regeneron Pharmaceuticals, Inc.
$258.0650
per ML
PRALUENT 150 MG/ML PEN
Brand
61755002102•Regeneron Pharmaceuticals, Inc.
$258.1639
per ML
REPATHA 140 MG/ML SYRINGE
Brand
72511050101•Amgen Inc.
$281.2448
per ML
REPATHA 140 MG/ML SYRINGE
Brand
72511075001•Amgen Inc.
$281.2448
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511039302•Amgen Inc.
$281.9492
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511076002•Amgen Inc.
$281.9492
per ML